All Stories

  1. Better prediction of blood clots in hospitalized COVID-19 patients

    Article • PLOS One, March 2025, PLOS

    Dr Mar Masiá, Sergio Padilla

  2. Evolving understanding of cardiovascular, cerebrovascular and peripheral arterial disease in people living with HIV and role of novel biomarkers. A study of the Spanish CoRIS cohort, 2004-2015

    Article • PLOS One, April 2019, PLOS

    Dr Mar Masiá

  3. La enseñanza de las enfermedades infecciosas en el grado de Medicina en el marco del espacio europeo de educación superior

    Article • Enfermedades Infecciosas y Microbiología Clínica, June 2016, Elsevier

    Dr Mar Masiá

  4. Deficiencia de vitamina D: ¿una pieza más en el puzle del riesgo cardiovascular de los pacientes con infección por el virus de la inmunodeficiencia humana?

    Article • Medicina Clínica, February 2015, Elsevier

    Dr Mar Masiá

  5. Cardiovascular risk factors and lifetime risk estimation in HIV-infected patients under antiretroviral treatment in Spain

    Article • HIV Clinical Trials, January 2015, Taylor & Francis

    Dr Mar Masiá

  6. First Human Systemic Infection Caused by Spiroplasma

    Article • Journal of Clinical Microbiology, November 2014, ASM Journals

    Dr Mar Masiá

  7. Coinfection with Human Herpesvirus 8 Is Associated with Persistent Inflammation and Immune Activation in Virologically Suppressed HIV-Infected Patients

    Article • PLOS One, August 2014, PLOS

    Dr Mar Masiá, Blanca Lumbreras

  8. Reproductive desire in women with HIV infection in Spain, associated factors and motivations: a mixed-method study

    Article • BMC Pregnancy and Childbirth, June 2014, Springer Science + Business Media

    Dr Mar Masiá

  9. Recurrence of active tuberculosis following resumption of anti-TNF-α therapy in a patient with Crohn's disease [Correspondence]

    Article • The International Journal of Tuberculosis and Lung Disease, February 2014, International Union Against Tuberculosis and Lung Disease

    Dr Mar Masiá

  10. Increased Carotid Intima-Media Thickness Associated with Antibody Responses to Varicella-Zoster Virus and Cytomegalovirus in HIV-Infected Patients

    Article • PLOS One, May 2013, PLOS

    Dr Mar Masiá

  11. Incidence and risk factors of AIDS-defining cancers in a cohort of HIV-positive adults: Importance of the definition of incident cases

    Article • Enfermedades Infecciosas y Microbiología Clínica, May 2013, Elsevier

    Dr Mar Masiá

  12. Riesgo cardiovascular en pacientes con infección por el virus de la inmunodeficiencia humana en España. Respuesta del autor

    Article • Enfermedades Infecciosas y Microbiología Clínica, April 2013, Elsevier

    Dr Mar Masiá

  13. Human Infection with Rickettsia sibirica mongolitimonae , Spain, 2007–2011

    Article • Emerging Infectious Diseases, February 2013, Centers for Disease Control and Prevention (CDC)

    Dr Mar Masiá

  14. Risk, predictors, and mortality associated with non-AIDS events in newly diagnosed HIV-infected patients

    Article • AIDS, January 2013, Wolters Kluwer Health

    Dr Mar Masiá, Dr. Vicente Soriano

  15. Relevant gender differences in epidemiological profile, exposure to first antiretroviral regimen and survival in the Spanish AIDS Research Network

    Article • Antiviral Therapy, January 2013, International Medical Press

    Dr Mar Masiá

  16. 15. Evaluation of anal cytology versus high-resolution anoscopy (HRA) in the diagnosis of preneoplastic lesions in a multicenter HIV-infected Spanish Cohort (CoRIS-HRA): incorporation of cellular proliferation molecular markers into the algorithm

    Article • Sexual Health, January 2013, CSIRO Publishing

    Dr Mar Masiá

  17. Riesgo cardiovascular en pacientes con infección por el virus de la inmunodeficiencia humana en España. Cohorte CoRIS, 2011

    Article • Enfermedades Infecciosas y Microbiología Clínica, November 2012, Elsevier

    Dr Mar Masiá

  18. Contribution of Interferon gamma release assays testing to the diagnosis of latent tuberculosis infection in HIV-infected patients: A comparison of QuantiFERON-TB Gold In Tube, T-SPOT.TB and tuberculin skin test

    Article • BMC Infectious Diseases, July 2012, Springer Science + Business Media

    Dr Mar Masiá

  19. Negative effect of immunosuppressive therapy in the performance of the QuantiFERON Gold In-Tube test in patients with immune-mediated inflammatory diseases

    Article • Clinical and Experimental Medicine, June 2012, Springer Science + Business Media

    Dr Mar Masiá

  20. Short Communication: Early Changes in Parathyroid Hormone Concentrations in HIV-Infected Patients Initiating Antiretroviral Therapy with Tenofovir

    Article • AIDS Research and Human Retroviruses, March 2012, Mary Ann Liebert Inc

    Dr Mar Masiá

  21. ¿Es la infección por el virus de la inmunodeficiencia humana una enfermedad inflamatoria?

    Article • Medicina Clínica, February 2012, Elsevier

    Dr Mar Masiá

  22. Evolution of HIV-1 genotype in plasma RNA and peripheral blood mononuclear cells proviral DNA after interruption and resumption of antiretroviral therapy

    Article • Antiviral Therapy, January 2012, International Medical Press

    Dr Mar Masiá

  23. Short-term and long-term clinical and immunological consequences of stopping antiretroviral therapy in HIV-infected patients with preserved immune function

    Article • Antiviral Therapy, January 2012, International Medical Press

    Dr Mar Masiá

  24. Evaluation of endothelial function and subclinical atherosclerosis in association with hepatitis C virus in HIV-infected patients: a cross-sectional study

    Article • BMC Infectious Diseases, October 2011, Springer Science + Business Media

    Dr Mar Masiá

  25. Predictors of Pneumococcal Co-infection for Patients with Pandemic (H1N1) 2009 Influenza

    Article • Emerging Infectious Diseases, August 2011, Centers for Disease Control and Prevention (CDC)

    Dr Mar Masiá

  26. Seroprevalence of Toxoplasma gondii infection among immigrant and native pregnant women in Eastern Spain

    Article • Parasitology Research, May 2011, Springer Science + Business Media

    Dr Mar Masiá

  27. Enfermedades importadas y no importadas en la población inmigrante. Una década de experiencia desde una unidad de enfermedades infecciosas

    Article • Enfermedades Infecciosas y Microbiología Clínica, March 2011, Elsevier

    Dr Mar Masiá

  28. Early changes in inflammatory and pro-thrombotic biomarkers in patients initiating antiretroviral therapy with abacavir or tenofovir

    Article • BMC Infectious Diseases, February 2011, Springer Science + Business Media

    Dr Mar Masiá

  29. A Highly Sensitive and Specific Model for Predicting HIV-1 Tropism in Treatment-Experienced Patients Combining Interpretation of V3 Loop Sequences and Clinical Parameters

    Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, January 2011, Wolters Kluwer Health

    Dr Mar Masiá, Blanca Lumbreras, Dr. Vicente Soriano

  30. Evolution of HIV-1 genotype in plasma RNA and peripheral blood mononuclear cells proviral DNA after interruption and resumption of antiretroviral therapy

    Article • Antiviral Therapy, January 2011, International Medical Press

    Dr Mar Masiá

  31. Enfermedad arterial periférica: un nuevo desafío para los pacientes con infección por el virus de la inmunodeficiencia humana

    Article • Medicina Clínica, October 2010, Elsevier

    Dr Mar Masiá

  32. Severe acute renal failure associated with rhabdomyolysis during treatment with raltegravir. A call for caution

    Article • Journal of Infection, August 2010, Elsevier

    Dr Mar Masiá

  33. Diagnostic accuracy of sTREM-1 to identify infection in critically ill patients with systemic inflammatory response syndrome

    Article • Clinical Biochemistry, June 2010, Elsevier

    Dr Mar Masiá

  34. Endothelial function is impaired in HIV-infected patients with lipodystrophy

    Article • Antiviral Therapy, January 2010, International Medical Press

    Dr Mar Masiá

  35. Factores de riesgo cardiovascular dependientes de la infección por VIH

    Article • Enfermedades Infecciosas y Microbiología Clínica, September 2009, Elsevier

    Dr Mar Masiá

  36. Producción española sobre tuberculosis a través del MEDLINE (1997–2006)

    Article • Archivos de Bronconeumología, June 2009, Elsevier

    Dr Mar Masiá

  37. Spanish Scientific Research Output on Tuberculosis Indexed in MEDLINE, 1997-2006

    Article • Archivos de Bronconeumología, June 2009, Elsevier

    Dr Mar Masiá

  38. Relationship between ankle–brachial index and carotid intima-media thickness in HIV-infected patients

    Article • AIDS, July 2008, Wolters Kluwer Health

    Dr Mar Masiá

  39. High-Density Lipoprotein Cholesterol in HIV-Infected Patients: Evidence for an Association with HIV-1 Viral Load, Antiretroviral Therapy Status, and Regimen Composition

    Article • AIDS Patient Care and STDs, July 2008, Mary Ann Liebert Inc

    Dr Mar Masiá

  40. Patients Characteristics and Clinical Implications of Suboptimal CD4 T-Cell Gains After 1 Year of Successful Antiretroviral Therapy

    Article • Current HIV Research, March 2008, Bentham Science Publishers

    Dr Mar Masiá

  41. Improving Outcomes of Elderly Patients with Community-Acquired Pneumonia

    Article • Drugs & Aging, January 2008, Springer Science + Business Media

    Dr Mar Masiá

  42. Low Prevalence of Peripheral Arterial Disease in HIV-Infected Patients With Multiple Cardiovascular Risk Factors

    Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, January 2008, Wolters Kluwer Health

    Dr Mar Masiá

  43. The role of C-reactive protein as a marker for cardiovascular risk associated with antiretroviral therapy in HIV-infected patients

    Article • Atherosclerosis, November 2007, Elsevier

    Dr Mar Masiá

  44. Ultrasonography and Anthropometry for Measuring Regional Body Fat in HIV-Infected Patients

    Article • Current HIV Research, September 2007, Bentham Science Publishers

    Dr Mar Masiá

  45. Resistencia insulínica en pacientes con infección por el VIH en tratamiento prolongado con efavirenz, lopinavir/ritonavir y atazanavir

    Article • Medicina Clínica, July 2007, Elsevier

    Dr Mar Masiá

  46. Influence of Antiretroviral Therapy on Oxidative Stress and Cardiovascular Risk: A Prospective Cross-Sectional Study in HIV-Infected Patients

    Article • Clinical Therapeutics, July 2007, Elsevier

    Dr Mar Masiá

  47. Síndrome metabólico en pacientes infectados por el virus de la inmunodeficiencia humana en una cohorte del área mediterránea

    Article • Medicina Clínica, February 2007, Elsevier

    Dr Mar Masiá

  48. Fatal infection due to larval cysts of cestodes (neurocysticercosis and hydatid disease) in human immunodeficiency virus (HIV) infected patients in Spain: Report of two cases

    Article • Scandinavian Journal of Infectious Diseases, January 2007, Taylor & Francis

    Dr Mar Masiá

  49. Clinical Outcome of HIV-Infected Patients with Sustained Virologic Response to Antiretroviral Therapy: Long-Term Follow-Up of a Multicenter Cohort

    Article • PLOS One, December 2006, PLOS

    Dr Mar Masiá

  50. Alteraciones lipídicas y riesgo cardiovascular asociado a la terapia antirretroviral

    Article • Enfermedades Infecciosas y Microbiología Clínica, December 2006, Elsevier

    Dr Mar Masiá

  51. Techniques for measuring regional body fat: computed tomography may be suitable for evaluation of facial lipoatrophy

    Article • AIDS, November 2006, Wolters Kluwer Health

    Dr Mar Masiá

  52. Occult lymphadenopathic Kaposi's sarcoma associated with severe pulmonary hypertension: A clinical hint about the potential role of HHV-8 in HIV-related pulmonary hypertension?

    Article • Journal of Clinical Virology, October 2006, Elsevier

    Dr Mar Masiá

  53. The influence of age and gender on the population-based incidence of community-acquired pneumonia caused by different microbial pathogens

    Article • Journal of Infection, September 2006, Elsevier

    Dr Mar Masiá

  54. Unexpected improvement of sexual dysfunction during atazanavir therapy

    Article • AIDS, September 2005, Wolters Kluwer Health

    Dr Mar Masiá

  55. Fiebre Q aguda en la Comunidad Valenciana. Estudio de 30 casos

    Article • Enfermedades Infecciosas y Microbiología Clínica, August 2005, Elsevier

    Dr Mar Masiá

  56. Características clínicas y epidemiológicas de la infección por el VIH en extranjeros en Elche, España (1998-2003)

    Article • Enfermedades Infecciosas y Microbiología Clínica, August 2005, Elsevier

    Dr Mar Masiá

  57. Low Frequency of Renal Function Impairment During One-Year of Therapy with Tenofovir-Containing Regimens in the Real-World: A Case-Control Study

    Article • AIDS Patient Care and STDs, July 2005, Mary Ann Liebert Inc

    Dr Mar Masiá

  58. Geography of medical publications. An overview of HIV/AIDS research in 2003

    Article • AIDS, January 2005, Wolters Kluwer Health

    Dr Mar Masiá

  59. Tuberculosis en inmigrantes: diferencias clinicoepidemiológicas con la población autóctona (1999-2002)

    Article • Enfermedades Infecciosas y Microbiología Clínica, June 2004, Elsevier

    Dr Mar Masiá

  60. Actividad in vitro de caspofungina frente a aislados clínicos de Candida resistentes a fluconazol en pacientes con infección por el VIH

    Article • Enfermedades Infecciosas y Microbiología Clínica, June 2004, Elsevier

    Dr Mar Masiá

  61. Reactantes de fase aguda en la neumonía adquirida en la comunidad

    Article • Medicina Clínica, February 2004, Elsevier

    Dr Mar Masiá

  62. Legionella pneumophila en la neumonía adquirida en la comunidad: interpretación de las pruebas microbiológicas

    Article • Medicina Clínica, February 2004, Elsevier

    Dr Mar Masiá

  63. Reactantes de fase aguda en la neumonía adquirida en la comunidad

    Article • Medicina Clínica, January 2004, Elsevier

    Dr Mar Masiá

  64. Legionella pneumophila en la neumonía adquirida en la comunidad: interpretación de las pruebas microbiológicas

    Article • Medicina Clínica, January 2004, Elsevier

    Dr Mar Masiá

  65. Producción científica en España en enfermedades infecciosas (1991-2001): posición en el contexto de la Unión Europea

    Article • Enfermedades Infecciosas y Microbiología Clínica, January 2004, Elsevier

    Dr Mar Masiá

  66. Actividad in vitro de caspofungina frente a aislados clínicos de Candida resistentes a fluconazol en pacientes con infección por el VIH

    Article • Enfermedades Infecciosas y Microbiología Clínica, January 2004, Elsevier

    Dr Mar Masiá

  67. Tuberculosis en inmigrantes: diferencias clinicoepidemiológicas con la población autóctona (1999-2002)

    Article • Enfermedades Infecciosas y Microbiología Clínica, January 2004, Elsevier

    Dr Mar Masiá

  68. Producción científica en España en enfermedades infecciosas (1991-2001): posición en el contexto de la Unión Europea

    Article • Enfermedades Infecciosas y Microbiología Clínica, January 2004, Elsevier

    Dr Mar Masiá

  69. Cambios en el espectro de la morbilidad y la mortalidad de los ingresos hospitalarios de los pacientes con infección por el virus de la inmunodeficiencia humana durante la era del tratamiento antirretroviral de gran actividad

    Article • Medicina Clínica, January 2004, Elsevier

    Dr Mar Masiá

  70. Examen de salud en la población inmigrante: prevalencia de infección tuberculosa latente, hepatitis B, hepatitis C, infección por el VIH y sífilis

    Article • Enfermedades Infecciosas y Microbiología Clínica, December 2003, Elsevier

    Dr Mar Masiá

  71. Reply

    Article • Clinical Infectious Diseases, October 2003, Oxford University Press (OUP)

    Dr Mar Masiá

  72. Lopinavir Plasma Concentrations and Changes in Lipid Levels During Salvage Therapy with Lopinavir/Ritonavir-Containing Regimens

    Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, August 2003, Wolters Kluwer Health

    Dr Mar Masiá

  73. Criptococosis diseminada en inmigrantes colombianos con infección por el virus de la inmunodeficiencia humana

    Article • Medicina Clínica, April 2003, Elsevier

    Dr Mar Masiá

  74. Evaluation of the Immunochromatographic Binax NOW Assay for Detection of Streptococcus pneumoniae Urinary Antigen in a Prospective Study of Community‐Acquired Pneumonia in Spain

    Article • Clinical Infectious Diseases, February 2003, Oxford University Press (OUP)

    Dr Mar Masiá

  75. Criptococosis diseminada en inmigrantes colombianos con infección por el virus de la inmunodeficiencia humana

    Article • Medicina Clínica, January 2003, Elsevier

    Dr Mar Masiá

  76. Examen de salud en la población inmigrante: prevalencia de infección tuberculosa latente, hepatitis B, hepatitis C, infección por el VIH y sífilis

    Article • Enfermedades Infecciosas y Microbiología Clínica, January 2003, Elsevier

    Dr Mar Masiá

  77. Antifungal drug resistance to azoles and polyenes

    Article • The Lancet Infectious Diseases, September 2002, Elsevier

    Dr Mar Masiá

  78. Fulminant Hepatitis and Fatal Toxic Epidermal Necrolysis (Lyell Disease) Coincident With Clarithromycin Administration in an Alcoholic Patient Receiving Disulfiram Therapy

    Article • Archives of Internal Medicine, February 2002, American Medical Association (AMA)

    Dr Mar Masiá

  79. Avascular necrosis of the bone in HIV-infected patients: incidence and associated factors

    Article • AIDS, February 2002, Wolters Kluwer Health

    Dr Mar Masiá

  80. Alteraciones del hemograma en el examen de salud de la población inmigrante

    Article • Medicina Clínica, January 2002, Elsevier

    Dr Mar Masiá

  81. Neumonía adquirida en la comunidad asociada a infección por el virus de la gripe

    Article • Medicina Clínica, January 2002, Elsevier

    Dr Mar Masiá

  82. Factores asociados a la resistencia a los inhibidores de la proteasa del virus de la inmunodeficiencia humana

    Article • Medicina Clínica, January 2002, Elsevier

    Dr Mar Masiá

  83. Impact of a day‐care center on the appropriateness of hospital admissions and frequency of hospitalization in patients with HIV infection

    Article • Journal of Clinical Effectiveness, June 2001, Emerald

    Dr Mar Masiá

  84. Vacuna antigripal en pacientes infectados por el virus de la inmunodeficiencia humana con inmunodepresión grave. Efecto sobre los linfocitos CD4 y sobre la carga viral plasmática

    Article • Medicina Clínica, January 2001, Elsevier

    Dr Mar Masiá

  85. Malaria cerebral por Plasmodium falciparum de evolución fatal tras la realización de exanguinotransfusión

    Article • Medicina Clínica, January 2000, Elsevier

    Dr Mar Masiá

  86. Corynebacterium pseudodiphtheriticum: an easily missed respiratory pathogen in HIV-infected patients

    Article • Diagnostic Microbiology and Infectious Disease, April 1999, Elsevier

    Dr Mar Masiá

  87. Clinical presentation of HIV infection in patients aged 50 years or older

    Article • Journal of Infection, November 1998, Elsevier

    Dr Mar Masiá

  88. Vincristine as Therapy for Idiopathic Thrombocytopenic Purpura in Patients Infected with Human Immunodeficiency Virus

    Article • Clinical Infectious Diseases, May 1996, Oxford University Press (OUP)

    Dr Mar Masiá

  89. Staphylococcal Toxic Shock Syndrome Associated with Human Immunodeficiency Virus Infection: Report of a Case with Bacteremia

    Article • Clinical Infectious Diseases, May 1996, Oxford University Press (OUP)

    Dr Mar Masiá